Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Modulation of Type 5 Metabotropic Glutamate Receptor-Mediated Intracellular Calcium Mobilization by Regulator of G Protein Signaling 4 (RGS4) in Cultured Astrocytes

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Contributors:
      UCL - SSS/IONS/CEMO - Pôle Cellulaire et moléculaire
    • Publication Information:
      MDPI AG
    • Publication Date:
      2024
    • Collection:
      DIAL@USL-B (Université Saint-Louis, Bruxelles)
    • Abstract:
      Acting as GTPase activating proteins promoting the silencing of activated G-proteins, regulators of G protein signaling (RGSs) are generally considered negative modulators of cell signaling. In the CNS, the expression of RGS4 is altered in diverse pathologies and its upregulation was reported in astrocytes exposed to an inflammatory environment. In a model of cultured cortical astrocytes, we herein investigate the influence of RGS4 on intracellular calcium signaling mediated by type 5 metabotropic glutamate receptor (mGluR5), which is known to support the bidirectional communication between neurons and glial cells. RGS4 activity was manipulated by exposure to the inhibitor CCG 63802 or by infecting the cells with lentiviruses designed to achieve the silencing or overexpression of RGS4. The pharmacological inhibition or silencing of RGS4 resulted in a decrease in the percentage of cells responding to the mGluR5 agonist DHPG and in the proportion of cells showing typical calcium oscillations. Conversely, RGS4-lentivirus infection increased the percentage of cells showing calcium oscillations. While the physiological implication of cytosolic calcium oscillations in astrocytes is still under investigation, the fine-tuning of calcium signaling likely determines the coding of diverse biological events. Indirect signaling modulators such as RGS4 inhibitors, used in combination with receptor ligands, could pave the way for new therapeutic approaches for diverse neurological disorders with improved efficacy and selectivity.
    • ISSN:
      2073-4409
    • Relation:
      boreal:284738; http://hdl.handle.net/2078.1/284738; urn:EISSN:2073-4409
    • Accession Number:
      10.3390/cells13040291
    • Online Access:
      https://doi.org/10.3390/cells13040291
      http://hdl.handle.net/2078.1/284738
    • Rights:
      info:eu-repo/semantics/openAccess
    • Accession Number:
      edsbas.D0977BFC